Home
AXSM
AXSM News

Latest Axsome Therapeutics Inc. (AXSM) News on November 22, 2024

Axsome's Q3 Earnings Beat, Auvelity Drives Sales Growth, Stock Up

Zacks

8 days ago

Axsome's Q3 Earnings Beat, Auvelity Drives Sales Growth, Stock Up

Thomson Reuters StreetEvents

9 days ago

Q3 2024 Axsome Therapeutics Inc Earnings Call

Axsome Therapeutics (AXSM) Q3 2024 Earnings Call Transcript

Motley Fool

9 days ago

Axsome Therapeutics (AXSM) Q3 2024 Earnings Call Transcript

GuruFocus.com

9 days ago

Axsome Hits 52-Week High After Surging Nearly 5%--FDA Milestones Could Fuel Even Bigger Gains

Axsome Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire

10 days ago

Axsome Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

Axsome Therapeutics Presents Data from Its Leading Neuroscience Pipeline at NEI Congress 2024

GlobeNewswire

14 days ago

Axsome Therapeutics Presents Data from Its Leading Neuroscience Pipeline at NEI Congress 2024

Analysts Estimate Axsome Therapeutics (AXSM) to Report a Decline in Earnings: What to Look Out for

Zacks

16 days ago

Analysts Estimate Axsome Therapeutics (AXSM) to Report a Decline in Earnings: What to Look Out for

Axsome Therapeutics Presents Data from Multiple Programs Spanning Its Innovative Neuroscience Portfolio at Psych Congress 2024

GlobeNewswire

24 days ago

Axsome Therapeutics Presents Data from Multiple Programs Spanning Its Innovative Neuroscience Portfolio at Psych Congress 2024

3 Bargain Stocks to Buy in a Market That's Priced for Perfection

Motley Fool

a month ago

3 Bargain Stocks to Buy in a Market That's Priced for Perfection

Axsome Therapeutics to Report Third Quarter 2024 Financial Results on November 12

GlobeNewswire

a month ago

Axsome Therapeutics to Report Third Quarter 2024 Financial Results on November 12

1 Under-the-Radar Biotech Stock to Buy and Hold

Motley Fool

2 months ago

1 Under-the-Radar Biotech Stock to Buy and Hold

Axsome Therapeutics Presents Data from Multiple Programs at Sleep Europe 2024

GlobeNewswire

2 months ago

Axsome Therapeutics Presents Data from Multiple Programs at Sleep Europe 2024

FDA Accepts AXSM's NDA Resubmission for Migraine Drug, Stock Up

Zacks

3 months ago

FDA Accepts AXSM's NDA Resubmission for Migraine Drug, Stock Up

Axsome Therapeutics Announces FDA Acceptance of NDA Resubmission for AXS-07 for the Acute Treatment of Migraine

GlobeNewswire

3 months ago

Axsome Therapeutics Announces FDA Acceptance of NDA Resubmission for AXS-07 for the Acute Treatment of Migraine

Axsome Therapeutics to Participate in Investor Conferences in September

GlobeNewswire

3 months ago

Axsome Therapeutics to Participate in Investor Conferences in September

Axsome Therapeutics Reaches Agreement to Dismiss Sunosi® (Solriamfetol) Patent Litigation with Sandoz Inc.

GlobeNewswire

3 months ago

Axsome Therapeutics Reaches Agreement to Dismiss Sunosi® (Solriamfetol) Patent Litigation with Sandoz Inc.

Jim Cramer Thinks Axsome Therapeutics Inc (NASDAQ:AXSM) Stock Can Double

Insider Monkey

3 months ago

Jim Cramer Thinks Axsome Therapeutics Inc (NASDAQ:AXSM) Stock Can Double

Axsome Therapeutics (AXSM) Q2 2024 Earnings Call Transcript

Motley Fool

4 months ago

Axsome Therapeutics (AXSM) Q2 2024 Earnings Call Transcript

Why Axsome Therapeutics Stock Is Sinking Today

Motley Fool

4 months ago

Why Axsome Therapeutics Stock Is Sinking Today

Axsome (AXSM) Q2 Loss Widens Y/Y, Revenues Beat Estimates

Zacks

4 months ago

Axsome (AXSM) Q2 Loss Widens Y/Y, Revenues Beat Estimates

Axsome Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire

4 months ago

Axsome Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

Axsome Therapeutics, Inc.'s (NASDAQ:AXSM) Shift From Loss To Profit

Simply Wall St.

4 months ago

Axsome Therapeutics, Inc.'s (NASDAQ:AXSM) Shift From Loss To Profit

Zacks Industry Outlook Highlights Moderna, Sarepta Therapeutics, Halozyme Therapeutics, Krystal Biotech and Axsome Therapeutics

Zacks

4 months ago

Zacks Industry Outlook Highlights Moderna, Sarepta Therapeutics, Halozyme Therapeutics, Krystal Biotech and Axsome Therapeutics

Axsome Therapeutics' CNS Portfolio Poised for Major Growth - Analyst Predicts Strong Future

Benzinga

4 months ago

Axsome Therapeutics' CNS Portfolio Poised for Major Growth - Analyst Predicts Strong Future

Bull Market and Beyond: 2 Stocks Just Waiting to Soar

Motley Fool

4 months ago

Bull Market and Beyond: 2 Stocks Just Waiting to Soar

Axsome Therapeutics to Report Second Quarter 2024 Financial Results on August 5

GlobeNewswire

4 months ago

Axsome Therapeutics to Report Second Quarter 2024 Financial Results on August 5

Investors ignore increasing losses at Axsome Therapeutics (NASDAQ:AXSM) as stock jumps 7.0% this past week

Simply Wall St.

5 months ago

Investors ignore increasing losses at Axsome Therapeutics (NASDAQ:AXSM) as stock jumps 7.0% this past week

Why Axsome Therapeutics Stock Is Sinking Today

Motley Fool

5 months ago

Why Axsome Therapeutics Stock Is Sinking Today

Axsome Therapeutics Settles Sunosi® (solriamfetol) Patent Litigation with Unichem Laboratories

GlobeNewswire

6 months ago

Axsome Therapeutics Settles Sunosi® (solriamfetol) Patent Litigation with Unichem Laboratories

Axsome Therapeutics Joins the American Migraine Foundation to Highlight Unmet Treatment Needs During Migraine & Headache Awareness Month

GlobeNewswire

6 months ago

Axsome Therapeutics Joins the American Migraine Foundation to Highlight Unmet Treatment Needs During Migraine & Headache Awareness Month

Axsome Therapeutics Supports Alzheimer’s & Brain Awareness Month

GlobeNewswire

6 months ago

Axsome Therapeutics Supports Alzheimer’s & Brain Awareness Month

Axsome Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire

6 months ago

Axsome Therapeutics to Participate in Upcoming Investor Conferences

Axsome Therapeutics Highlights Data on Solriamfetol Demonstrating Improvement in Cognitive Function in Patients with Obstructive Sleep Apnea or Narcolepsy at SLEEP 2024

GlobeNewswire

6 months ago

Axsome Therapeutics Highlights Data on Solriamfetol Demonstrating Improvement in Cognitive Function in Patients with Obstructive Sleep Apnea or Narcolepsy at SLEEP 2024

Axsome Therapeutics Presents Data from Multiple Programs at the 2024 American Society of Clinical Psychopharmacology Annual (ASCP) Meeting

GlobeNewswire

6 months ago

Axsome Therapeutics Presents Data from Multiple Programs at the 2024 American Society of Clinical Psychopharmacology Annual (ASCP) Meeting

3 Monster Stocks in the Making You Can Buy Right Now

Motley Fool

6 months ago

3 Monster Stocks in the Making You Can Buy Right Now

15 Most Depressed States in the US

Insider Monkey

6 months ago

15 Most Depressed States in the US

Prediction: These 2 Growth Stocks Could Triple By 2030

Motley Fool

6 months ago

Prediction: These 2 Growth Stocks Could Triple By 2030

Axsome Therapeutics, Inc. (NASDAQ:AXSM) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

Simply Wall St.

6 months ago

Axsome Therapeutics, Inc. (NASDAQ:AXSM) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

Axsome Therapeutics to Present at Upcoming Investor Conferences

GlobeNewswire

6 months ago

Axsome Therapeutics to Present at Upcoming Investor Conferences

Axsome (AXSM) Q1 Loss Widens Y/Y, Revenues Beat Estimates

Zacks

6 months ago

Axsome (AXSM) Q1 Loss Widens Y/Y, Revenues Beat Estimates

Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q1 2024 Earnings Call Transcript

Insider Monkey

6 months ago

Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q1 2024 Earnings Call Transcript

GuruFocus.com

6 months ago

Axsome Therapeutics Inc (AXSM) (Q1 2024) Earnings Call Transcript Highlights: Soaring Revenues ...

Thomson Reuters StreetEvents

6 months ago

Q1 2024 Axsome Therapeutics Inc Earnings Call

Axsome Therapeutics (AXSM) Q1 2024 Earnings Call Transcript

Motley Fool

7 months ago

Axsome Therapeutics (AXSM) Q1 2024 Earnings Call Transcript

Axsome Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire

7 months ago

Axsome Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

Should You Buy Axsome Therapeutics (AXSM) Ahead of Earnings?

Zacks

7 months ago

Should You Buy Axsome Therapeutics (AXSM) Ahead of Earnings?

Axsome Therapeutics Recognizes May as Mental Health Awareness Month

GlobeNewswire

7 months ago

Axsome Therapeutics Recognizes May as Mental Health Awareness Month

15 Most Black States in the US

Insider Monkey

7 months ago

15 Most Black States in the US

Axsome Therapeutics Highlights Innovative Neuroscience Portfolio at the American Academy of Neurology (AAN) 2024 Annual Meeting

GlobeNewswire

7 months ago

Axsome Therapeutics Highlights Innovative Neuroscience Portfolio at the American Academy of Neurology (AAN) 2024 Annual Meeting

Axsome Therapeutics to Report First Quarter 2024 Financial Results on May 6

GlobeNewswire

7 months ago

Axsome Therapeutics to Report First Quarter 2024 Financial Results on May 6

Axsome (AXSM) Begins Solriamfetol Binge Eating Phase III Study

Zacks

8 months ago

Axsome (AXSM) Begins Solriamfetol Binge Eating Phase III Study

Insider Sell: COO Mark Jacobson Sells 24,662 Shares of Axsome Therapeutics Inc (AXSM)

GuruFocus.com

8 months ago

Insider Sell: COO Mark Jacobson Sells 24,662 Shares of Axsome Therapeutics Inc (AXSM)

Axsome Therapeutics Initiates ENGAGE Phase 3 Trial of Solriamfetol for the Treatment of Binge Eating Disorder

GlobeNewswire

8 months ago

Axsome Therapeutics Initiates ENGAGE Phase 3 Trial of Solriamfetol for the Treatment of Binge Eating Disorder

30 Countries with the Lowest Depression Rates

Insider Monkey

8 months ago

30 Countries with the Lowest Depression Rates

20 Cloudiest Cities in the U.S., Ranked

Insider Monkey

8 months ago

20 Cloudiest Cities in the U.S., Ranked

Axsome Therapeutics Announces Results of CRESCENDO Narcolepsy Patient Survey Demonstrating Unmet Needs in Treated Narcolepsy Type 1 Patients

GlobeNewswire

8 months ago

Axsome Therapeutics Announces Results of CRESCENDO Narcolepsy Patient Survey Demonstrating Unmet Needs in Treated Narcolepsy Type 1 Patients

Axsome Therapeutics Announces AXS-12 Achieves Primary Endpoint in the SYMPHONY Phase 3 Trial in Narcolepsy

GlobeNewswire

8 months ago

Axsome Therapeutics Announces AXS-12 Achieves Primary Endpoint in the SYMPHONY Phase 3 Trial in Narcolepsy

Buying These Dirt-Cheap Stocks Could Be a Brilliant Move

Motley Fool

8 months ago

Buying These Dirt-Cheap Stocks Could Be a Brilliant Move

Axsome Triumphs Over Major Depressive Disorder With Auvelity

GuruFocus.com

8 months ago

Axsome Triumphs Over Major Depressive Disorder With Auvelity

Axsome (AXSM) Begins Dosing in Depression Study on Sunosi

Zacks

8 months ago

Axsome (AXSM) Begins Dosing in Depression Study on Sunosi

Axsome Therapeutics Initiates PARADIGM Phase 3 Trial of Solriamfetol for the Treatment of Major Depressive Disorder

GlobeNewswire

8 months ago

Axsome Therapeutics Initiates PARADIGM Phase 3 Trial of Solriamfetol for the Treatment of Major Depressive Disorder

11 Oversold NASDAQ Stocks To Buy Right Now

Insider Monkey

8 months ago

11 Oversold NASDAQ Stocks To Buy Right Now

Axsome Therapeutics to Present at the Leerink Partners Global Biopharma Conference

GlobeNewswire

9 months ago

Axsome Therapeutics to Present at the Leerink Partners Global Biopharma Conference

Axsome Therapeutics to Present at the TD Cowen 44th Annual Healthcare Conference

GlobeNewswire

9 months ago

Axsome Therapeutics to Present at the TD Cowen 44th Annual Healthcare Conference

3 Under-the-Radar Biotech Stocks With Upcoming Catalysts in 2024

InvestorPlace

9 months ago

3 Under-the-Radar Biotech Stocks With Upcoming Catalysts in 2024

3 Biotech Stocks to Buy and Hold for the Next 10 Years

Motley Fool

9 months ago

3 Biotech Stocks to Buy and Hold for the Next 10 Years

Axsome (AXSM) Stock Falls Despite Q4 Earnings & Revenue Beat

Zacks

9 months ago

Axsome (AXSM) Stock Falls Despite Q4 Earnings & Revenue Beat

Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q4 2023 Earnings Call Transcript

Insider Monkey

9 months ago

Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q4 2023 Earnings Call Transcript

Thomson Reuters StreetEvents

9 months ago

Q4 2023 Axsome Therapeutics Inc Earnings Call

Axsome Therapeutics Inc (AXSM) Reports Robust Revenue Growth in Q4 and Full Year 2023

GuruFocus.com

9 months ago

Axsome Therapeutics Inc (AXSM) Reports Robust Revenue Growth in Q4 and Full Year 2023

Axsome Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

GlobeNewswire

9 months ago

Axsome Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Axsome Therapeutics (AXSM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Zacks

9 months ago

Axsome Therapeutics (AXSM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Breakeven On The Horizon For Axsome Therapeutics, Inc. (NASDAQ:AXSM)

Simply Wall St.

9 months ago

Breakeven On The Horizon For Axsome Therapeutics, Inc. (NASDAQ:AXSM)

2 Stocks That Could Double Your Money in 5 Years

Motley Fool

9 months ago

2 Stocks That Could Double Your Money in 5 Years

Wayfair (NYSE:W) dips 10% this week as increasing losses might not be inspiring confidence among its investors

Simply Wall St.

10 months ago

Wayfair (NYSE:W) dips 10% this week as increasing losses might not be inspiring confidence among its investors

AutoNation Announces Fourth Quarter 2023 Earnings Conference Call and Audio Webcast Scheduled for Tuesday, February 13, 2024

PR Newswire

10 months ago

AutoNation Announces Fourth Quarter 2023 Earnings Conference Call and Audio Webcast Scheduled for Tuesday, February 13, 2024

A Motley Fool Co-Founder's Roller-Coaster Nvidia Story

Motley Fool

10 months ago

A Motley Fool Co-Founder's Roller-Coaster Nvidia Story

GlobeNewswire

10 months ago

Simplicity Group Unveils WeDYOR: Transforming Due Diligence for Crypto Investments

Automotive Telematics Market to Exceed USD 34.52 billion by 2031 | According to Transparency Market Research Analysis

GlobeNewswire

10 months ago

Automotive Telematics Market to Exceed USD 34.52 billion by 2031 | According to Transparency Market Research Analysis

Business Wire

10 months ago

Form 8.3 - DX (Group) plc

Global Disposable Gloves Market Size is Estimated to Reach USD 20.1 billion by 2031, Growing at a CAGR of 8.21%: Straits Research

GlobeNewswire

10 months ago

Global Disposable Gloves Market Size is Estimated to Reach USD 20.1 billion by 2031, Growing at a CAGR of 8.21%: Straits Research

SmallRig Founder and Chairman Zhou Yang Recognized as One of Forbes China's Inaugural Globalization Innovators Top30

CNW Group

10 months ago

SmallRig Founder and Chairman Zhou Yang Recognized as One of Forbes China's Inaugural Globalization Innovators Top30

Africa Smart Manufacturing Market Sees Upsurge: Comprehensive Analysis and Growth Forecasts Up to 2030

GlobeNewswire

10 months ago

Africa Smart Manufacturing Market Sees Upsurge: Comprehensive Analysis and Growth Forecasts Up to 2030

United Arab Emirates Smart Manufacturing Market Analysis Showcases Growth Trends and Opportunities up to 2030

GlobeNewswire

10 months ago

United Arab Emirates Smart Manufacturing Market Analysis Showcases Growth Trends and Opportunities up to 2030

SoFi Stock Soars After Company Posts First-Ever Quarterly Profit

Barrons.com

10 months ago

SoFi Stock Soars After Company Posts First-Ever Quarterly Profit

Phenomenex Launches PhenoAcademy for Cutting-Edge Chromatography Education

PR Newswire

10 months ago

Phenomenex Launches PhenoAcademy for Cutting-Edge Chromatography Education

CNA Financial (CNA) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Zacks

10 months ago

CNA Financial (CNA) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Big Tech earnings: What markets are expecting this week

Yahoo Finance Video

10 months ago

Big Tech earnings: What markets are expecting this week

Murphy Oil Corporation (NYSE:MUR) Q4 2023 Earnings Call Transcript

Insider Monkey

10 months ago

Murphy Oil Corporation (NYSE:MUR) Q4 2023 Earnings Call Transcript

Baillie Gifford Trims Stake in Samsara Inc

GuruFocus.com

10 months ago

Baillie Gifford Trims Stake in Samsara Inc

5 Top Growth Stocks to Buy as Recession Fears Subside

Zacks

10 months ago

5 Top Growth Stocks to Buy as Recession Fears Subside

Murphy Oil Full Year 2023 Earnings: EPS Misses Expectations

Simply Wall St.

10 months ago

Murphy Oil Full Year 2023 Earnings: EPS Misses Expectations

Director Tim Bentsen Sells 4,671 Shares of Synovus Financial Corp (SNV)

GuruFocus.com

10 months ago

Director Tim Bentsen Sells 4,671 Shares of Synovus Financial Corp (SNV)

Here's How Clorox (CLX) is Placed Just Ahead of Q2 Earnings

Zacks

10 months ago

Here's How Clorox (CLX) is Placed Just Ahead of Q2 Earnings

ADT Provides Solar Business Update and Advances Capital Allocation Strategy

GlobeNewswire

10 months ago

ADT Provides Solar Business Update and Advances Capital Allocation Strategy

Venmo and other payment app theft is ‘skyrocketing,’ Manhattan DA warns

CNN Business

10 months ago

Venmo and other payment app theft is ‘skyrocketing,’ Manhattan DA warns

Axsome Therapeutics Stock Showing Leadership, Earns 91 RS Rating

Investor's Business Daily

10 months ago

Axsome Therapeutics Stock Showing Leadership, Earns 91 RS Rating

Biognosys Expands US Footprint with New Proteomics CRO Facility in Massachusetts

Business Wire

10 months ago

Biognosys Expands US Footprint with New Proteomics CRO Facility in Massachusetts

Axsome Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on February 20

GlobeNewswire

10 months ago

Axsome Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on February 20

My 3 Favorite Stocks to Buy Right Now

Motley Fool

10 months ago

My 3 Favorite Stocks to Buy Right Now

Share on Social Networks: